ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1728

Takayasu’s Arteritis and Pregnancy: A Meta-analysis

Aine Gorman1, Leah Rooney2, Matthew Turk1, Louise Moore3, Jared Bierbrier4, Celine O'Brien5, Anne Clohessy6, Eamonn Molloy7, Lorraine O Neill8, Fionnuala McAuliffe9 and Douglas Veale10, 1St Vincents Hospital, Dublin, Ireland, 2St Vincent's University Hospital, Dublin, Ireland, 3Our Lady's Hospice and Care Services, Harold's Cross, Dublin 6W, Kinnegad, Ireland, 4McMaster University, Hamilton, ON, Canada, 5Perinatal Research Centre, Obstetrics and Gynaecology, School of Medicine, University College Dublin and National Maternity Hospital, Dublin, Dublin, Ireland, 6National Maternity Hopistal, Dublin, Ireland, 7St Vincent's Healthcare Group, Dublin, Ireland, 8St. Vincent's Hospital, Dublin, Ireland, 9National Maternity Hopsital Dublin, Dublin, Ireland, 10University College Dublin, Dublin, Ireland

Meeting: ACR Convergence 2021

Keywords: meta-analysis, pregnancy, Takayasu.s arteritis, Vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 9, 2021

Title: Reproductive Issues in Rheumatic Disorders Poster (1711–1731)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Takayasu’s arteritis is a systemic autoimmune disease characterised by large vessel vasculitis. It usually affects women of childbearing age, with 90% of patients diagnosed < 30 years of age, and previous studies suggest it is associated with adverse pregnancy outcomes. There is a vast discrepancy within the literature; some studies suggest preeclampsia occurring in 4.5% of patients, while others suggest a rate of 61%. The purpose of our work was to determine the prevalence of both maternal and fetal outcomes in patients with Takayasu’s arteritis through a systematic review and meta-analysis.

Methods: We performed a systematic review of the literature using Medline, Web of Science, and the Cochrane library from their inceptions until March 26, 2021, to identify studies that reported pregnancy outcomes in patients with Takayasu’s arteritis. Demographic information, maternal outcomes, foetal outcomes, prednisolone use, and information on disease activity were extracted from studies. Two authors independently selected the studies, extracted the data and assessed for risk of bias.

Results: Our systematic review identified 6638 abstracts, of which 23 articles were included. The miscarriage rate was 11 [7-16] % and an intrauterine death rate of 1[0-3] %. Preeclampsia was reported in 10[7-12] % of patients (Figure 1). Preterm delivery occurred in 15[12-19] %. New hypertension in pregnancy was reported in 12[8-16] %. Intrauterine growth restriction occurred in 16[10-21] % of pregnancies. The prevalence of caesarean sections among Takayasu patients was 28 [22-28] % (Figure 2). In terms of fetal outcomes, low birth weight was associated with 16[10-21] % of live births (Figure 3). Flares of vasculitis occurred in 11[8-15] % of patients.

Conclusion: There is a high prevalence of both maternal and fetal adverse outcomes in pregnant patients with Takayasu’s arteritis, who require careful management by a multidisciplinary team during pregnancy.

Figure 1: Prevalence of preeclampsia in Takayasu’s arteritis patients

Figure 2: Prevalence of caesarean section in Takayasu patients

Figure 3: Prevalence of low birth weight among Takayasu patients


Disclosures: A. Gorman, None; L. Rooney, None; M. Turk, None; L. Moore, None; J. Bierbrier, None; C. O'Brien, None; A. Clohessy, None; E. Molloy, None; L. O Neill, None; F. McAuliffe, None; D. Veale, Abbvie, 1, 5, 6, BMS, 1, 5, Pfizer, 1, 5, 6, Janssen, 1, 5, 6, Eli Lilly, 1, 5, 6, UCB, 1, 5, 6, Novartis, 1, 5, 6, Galapagos/Gilead, 1, 6.

To cite this abstract in AMA style:

Gorman A, Rooney L, Turk M, Moore L, Bierbrier J, O'Brien C, Clohessy A, Molloy E, O Neill L, McAuliffe F, Veale D. Takayasu’s Arteritis and Pregnancy: A Meta-analysis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/takayasus-arteritis-and-pregnancy-a-meta-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/takayasus-arteritis-and-pregnancy-a-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology